These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 6406026)
41. In vivo production of exotoxin A and its role in endogenous Pseudomonas aeruginosa septicemia in mice. Hirakata Y; Furuya N; Tateda K; Kaku M; Yamaguchi K Infect Immun; 1993 Jun; 61(6):2468-73. PubMed ID: 8500881 [TBL] [Abstract][Full Text] [Related]
42. Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites. Woods DE; Schaffer MS; Rabin HR; Campbell GD; Sokol PA J Clin Microbiol; 1986 Aug; 24(2):260-4. PubMed ID: 3018037 [TBL] [Abstract][Full Text] [Related]
43. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis. Hollsing AE; Granström M; Vasil ML; Wretlind B; Strandvik B J Clin Microbiol; 1987 Oct; 25(10):1868-74. PubMed ID: 3117842 [TBL] [Abstract][Full Text] [Related]
44. Impairment of host defence by exotoxin A in Pseudomonas aeruginosa pneumonia in mice. Schultz MJ; Rijneveld AW; Florquin S; Speelman P; VAN Deventer SJH; VAN DER Poll T J Med Microbiol; 2001 Sep; 50(9):822-827. PubMed ID: 11549184 [TBL] [Abstract][Full Text] [Related]
45. Induction of tumor necrosis factor (TNF) and interleukin-1 (IL-1) by Pseudomonas aeruginosa and exotoxin A-induced suppression of lymphoproliferation and TNF, lymphotoxin, gamma interferon, and IL-1 production in human leukocytes. Staugas RE; Harvey DP; Ferrante A; Nandoskar M; Allison AC Infect Immun; 1992 Aug; 60(8):3162-8. PubMed ID: 1639487 [TBL] [Abstract][Full Text] [Related]
46. Preparation of recombinant atoxic form of exotoxin A from Pseudomonas aeruginosa. Kaloshin AA; Isakov MA; Mikhailova NA; Vertiev JV Bull Exp Biol Med; 2013 Jan; 154(3):346-50. PubMed ID: 23484197 [TBL] [Abstract][Full Text] [Related]
47. Antibody titers in serum of diffuse panbronchiolitis patients administered a multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase and exotoxin A and a common protective antigen (OEP). Yamamoto M; Kubota Y; Matsuura M; Homma JY Kitasato Arch Exp Med; 1988 Sep; 61(2-3):127-35. PubMed ID: 3145352 [No Abstract] [Full Text] [Related]
48. The pathogenesis of infections owing to Pseudomonas aeruginosa using the burned mouse model: experimental studies from the Shriners Burns Institute, Cincinnati. Holder IA Can J Microbiol; 1985 Apr; 31(4):393-402. PubMed ID: 3924388 [No Abstract] [Full Text] [Related]
49. [Prevelance of antibodies ot OEP, exotoxin A, and exoenzymes of Pseudomonas aeruginosa in man (author's transl)]. Shinozaki T; Fujii R; Sanai Y; Homma JY Kansenshogaku Zasshi; 1981 Jan; 55(1):32-40. PubMed ID: 6788869 [No Abstract] [Full Text] [Related]
50. Clearance of Pseudomonas aeruginosa from normal rat lungs after immunization with somatic antigens or toxin A. Johansen HK; Cryz SJ; Høiby N APMIS; 1994 Jul; 102(7):545-53. PubMed ID: 7917224 [TBL] [Abstract][Full Text] [Related]
51. [Immunobiological properties of recombinant atoxic forms of the Pseudomonas aeruginosa exotoxin A]. Isakov MA; Soldatenkova AS; Kaloshin AA; Mikhaĭlova NA Zh Mikrobiol Epidemiol Immunobiol; 2011; (2):37-42. PubMed ID: 21598613 [TBL] [Abstract][Full Text] [Related]
52. Pseudomonas aeruginosa and epithelial permeability: role of virulence factors elastase and exotoxin A. Azghani AO Am J Respir Cell Mol Biol; 1996 Jul; 15(1):132-40. PubMed ID: 8679217 [TBL] [Abstract][Full Text] [Related]
53. Alteration of murine immune response by Pseudomonas aeruginosa exotoxin A. Holt PS; Misfeldt ML Infect Immun; 1984 Jul; 45(1):227-33. PubMed ID: 6429047 [TBL] [Abstract][Full Text] [Related]
54. The role of exotoxin A in pseudomonas disease and immunity. Pollack M Rev Infect Dis; 1983; 5 Suppl 5():S979-84. PubMed ID: 6419320 [TBL] [Abstract][Full Text] [Related]
55. Recombinant DNA approaches to the study of the regulation of virulence factors and epidemiology of Pseudomonas aeruginosa. Vasil ML; Ogle JW; Grant CC; Vasil AI Antibiot Chemother (1971); 1987; 39():264-78. PubMed ID: 3118789 [No Abstract] [Full Text] [Related]
56. Active immunization using exotoxin A confers protection against Pseudomonas aeruginosa infection in a mouse burn model. Manafi A; Kohanteb J; Mehrabani D; Japoni A; Amini M; Naghmachi M; Zaghi AH; Khalili N BMC Microbiol; 2009 Feb; 9():23. PubMed ID: 19183501 [TBL] [Abstract][Full Text] [Related]
57. Hypoxia Reduces the Pathogenicity of Pseudomonas aeruginosa by Decreasing the Expression of Multiple Virulence Factors. Schaible B; Rodriguez J; Garcia A; von Kriegsheim A; McClean S; Hickey C; Keogh CE; Brown E; Schaffer K; Broquet A; Taylor CT J Infect Dis; 2017 May; 215(9):1459-1467. PubMed ID: 28368464 [TBL] [Abstract][Full Text] [Related]
58. Serum antibody concentrations of cytotoxin, exotoxin, A, lipopolysaccharide, protease, and elastase and survival of patients with Pseudomonas aeruginosa bacteremia. Baltch AL; Franke M; Smith RP; Asperilla M; Griffin P; Michelsen P; Lutz F Clin Infect Dis; 1996 Nov; 23(5):1109-16. PubMed ID: 8922810 [TBL] [Abstract][Full Text] [Related]
59. Amount, avidity, and specificity of antibodies to Pseudomonas aeruginosa in normal human sera. Grzybowski J; Trafny EA; Wrembel-Wargocka J; Patzer J; Dzierzanowska D; Zawistowska-Marciniak I; Kłos M J Clin Microbiol; 1989 Jun; 27(6):1367-71. PubMed ID: 2502560 [TBL] [Abstract][Full Text] [Related]
60. Contribution of exoenzyme S to the virulence of Pseudomonas aeruginosa. Nicas TI; Iglewski BH Antibiot Chemother (1971); 1985; 36():40-8. PubMed ID: 2988426 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]